Search

Your search keyword '"Sauta, Elisabetta"' showing total 45 results

Search Constraints

Start Over You searched for: Author "Sauta, Elisabetta" Remove constraint Author: "Sauta, Elisabetta"
45 results on '"Sauta, Elisabetta"'

Search Results

2. The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling

3. A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study

5. Personalized Timing for Allogeneic Stem-Cell Transplantation in Hematologic Neoplasms: A Target Trial Emulation Approach Using Multistate Modeling and Microsimulation

7. Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes.

8. HELLS regulates transcription in T-cell lymphomas by reducing unscheduled R-loops and by facilitating RNAPII progression

9. MOSAIC: An Artificial Intelligence–Based Framework for Multimodal Analysis, Classification, and Personalized Prognostic Assessment in Rare Cancers.

12. Data Fusion Approach for Learning Transcriptional Bayesian Networks

16. Long non-coding RNA mitophagy and ALK-negative anaplastic lymphoma-associated transcript: a novel regulator of mitophagy in T-cell lymphoma

17. Synthetic Data Generation by Artificial Intelligence to Accelerate Research and Precision Medicine in Hematology

18. Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

21. Synthetic Data Generation by Artificial Intelligence to Accelerate Research and Precision Medicine in Hematology

22. Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

23. Abstract A22: Deciphering natural killer transcriptional activation in triple-negative breast cancer: A novel opportunity for adoptive cell therapies?

24. Real-World Validation of Molecular International Prognostic Scoring System (IPSS-M) for Myelodysplastic Syndromes

25. Multi-Modal Analysis and Federated Learning Approach for Classification and Personalized Prognostic Assessment in Myeloid Neoplasms

26. Synthetic Data Generation By Artificial Intelligence to Accelerate Translational Research and Precision Medicine in Hematological Malignancies

27. Clinical Implications of p53 Dysfunction in Patients with Myelodysplastic Syndromes

29. KAP1 is a new non-genetic vulnerability of malignant pleural mesothelioma (MPM)

31. Tumor‐associated macrophages and risk of recurrence in stage III colorectal cancer

33. Combining Gene Mutation with Transcriptomic Data Improves Outcome Prediction in Myelodysplastic Syndromes

34. CSNK1A1, KDM2A, and LTB4R2 Are New Druggable Vulnerabilities in Lung Cancer

35. Linc00941 Is a Novel Transforming Growth Factor β Target That Primes Papillary Thyroid Cancer Metastatic Behavior by Regulating the Expression of Cadherin 6

37. Comparative Study of Salivary, Duodenal, and Fecal Microbiota Composition Across Adult Celiac Disease

40. Data-Driven Harmonization of 2022 Who and ICC Classifications of Myelodysplastic Syndromes/Neoplasms (MDS): A Study By the International Consortium for MDS (icMDS)

41. Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelodysplastic Syndromes (MDS)

42. Clinical Text Reports to Stratify Patients Affected with Myeloid Neoplasms Using Natural Language Processing

43. Molecular Classification of Chronic Myelomonocytic Leukemia: Results of the Analysis of an International Cohort of 2,471 Patients

44. Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes.

45. The Search for Molecular Markers in a Gene-Orphan Case Study of a Pediatric Spinal Cord Pilocytic Astrocytoma.

Catalog

Books, media, physical & digital resources